Ukraine's rapidly scaling defense industry is changing how the West thinks about future wars
While Russia leans on the brute force of its military-industrial complex — nearly 695,000 troops, relentless missile barrages, and escalating drone strikes — Ukraine has turned necessity into invention.
Its growing defense sector is producing drones, robotic land vehicles, and other advanced systems on timelines and budgets that would be unthinkable for most Western militaries.
"The ability of Ukraine's industry to build drones at scale and adapt them in response to changing battlefield conditions creates a model that other militaries are striving now to follow," Bryan Clark, a senior fellow at the Hudson Institute, told Business Insider.
He added: "Although the small FPV drones used by both sides may not have utility in a war against China, the approach of building systems on demand using modular components is beginning to emerge in the US industrial base as well."
This transformation has been made possible by Ukraine upending traditional military procurement models.
"Necessity and urgency breed true innovation," Emily Harding, vice president of the defense and security department at the Center for Strategic and International Studies, told BI.
"Ukraine has found a way to upend normal cycles of development and procurement to get troops updated equipment within weeks," she added.
One key aspect has been to directly connect defense startups with soldiers on the ground.
"Linking companies directly with units in the field turns the innovation cycle into a flywheel — rapid feedback, adaptation, sales, and deployment to the front lines," Harding said.
Doug Klain, a nonresident fellow at the Atlantic Council's Eurasia Center, argues that Ukraine isn't just catching up — it's pointing the way forward for other countries.
"Where American defense producers take years to iterate and update systems based on testing before redeploying, Ukrainians are making significant updates within weeks to overcome Russian countermeasures," he said.
Meanwhile, Ukraine's shift toward indigenous production is accelerating.
Ukrainian President Volodymyr Zelenskyy said that roughly 40% of Ukraine's weapons now come from domestic sources — an impressive figure for a country under attack.
Klain said that Ukraine is also becoming more than just the frontline of Europe's defense.
"Far from being a recipient of assistance, Ukraine is a value-add," he told BI. "There is no more experienced army in resisting Russian aggression today, and its defense industry is increasingly tailored to the scale and specialties required for defending Europe."
Ukrainian defense startups like TenCore — founded in early 2024 with five employees — highlight this shift. With 175 employees and projecting $80 million in revenue this year, the company has delivered more than 2,000 battlefield systems and turned down acquisition offers to remain independent.
Western militaries are taking notice.
Ukraine's innovative use of drones and other AI-enabled autonomous systems has "revolutionized the role these technologies play in modern warfare — from logistics to long-range strikes," Lauren Speranza, a fellow at the Center for European Policy Analysis, told BI.
"Modern war between peer competitors is clearly a war of defense industrial bases as much as of men and maneuver," added Harding. "A country that cannot adapt to developments on the battlefield and sustain the warfighters is sure to lose."
Even so, military experts caution against wholesale replication in the West.
"Western militaries can't over-index on what Ukraine is doing in terms of specific systems because the conditions are unique," Hudson Institute's Clark said.
However, he added that leveraging militarily relevant commercial technology "will be essential for gaining an advantage in the 21st century."
Lessons may also extend to how future wars are conceptualized.
"Ukraine has effectively replaced artillery with drones for entrenched warfare," said Michael O'Hanlon, director of research in foreign policy at the Brookings Institution.
"That doesn't change everything about modern combat, but it changes a lot," he added, "and points the way to future close-in fights where drone swarms may dominate."
Still, Ukraine's ability to scale remains limited by one major factor: money. With a $12 billion defense budget, officials estimate that the country's production capacity is a third of its true potential.
Kyiv is now pushing to attract more Western investment and is eyeing initiatives like the EU's proposed SAFE project — a $150 billion fund designed to strengthen European defense manufacturing.
"Ukraine is integral in any future European security architecture," Klain said. "It has genuine lessons to offer as we all figure out how to revitalize defense industries that just aren't up to the needs of modern warfare."
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

Yahoo
9 minutes ago
- Yahoo
Funeral in a village near Kyiv of family members killed in Russian missile strike
Dozens of people gathered on Monday in Ivankovychi, a village outside Kyiv, to bury four members of the Haiovyi family – a mother and her two sons, along with her brother – all killed during a Russian missile strike on July 31. (AP video by Oleksii Yeroshenko)


New York Post
10 minutes ago
- New York Post
Trump envoy Witkoff urged to take tough approach with Putin in make-or-break meeting to end Ukraine war before sanctions
WASHINGTON — The Trump administration is giving Russian President Vladimir Putin one more chance to show he's serious about ending his 41-month-old invasion of Ukraine. As more than six months have passed with no diplomatic progress, well-placed sources tell The Post special envoy Steve Witkoff has been encouraged to take a sterner approach with Moscow's leader ahead of Wednesday's make-or-break meeting — in line with President Trump's recent expressions of disgust at Putin's continued attacks on Ukrainian civilians. Whether Witkoff will take that advice remains unclear. Advertisement 3 President Trump is giving Russian President Vladimir Putin one last chance to end the Russian invasion of Ukraine that started over 3 years ago. via REUTERS A spokesperson for the special envoy declined to comment on the record for this story. Meanwhile, the White House national security team responsible for the Ukraine war held multiple meetings on Tuesday, trying to work out how Washington might best persuade Russia to silence its guns, according to people familiar with the matter. Advertisement Trump himself said Tuesday he would wait to see how the sitdown went before making a final decision on whether to enact secondary sanctions and slapping more tariffs on countries that provide Russia with its main source of income: oil purchases. 'We have a meeting with Russia tomorrow, we're going to see what happens. We'll make a determination at that time,' said the president, before denying that he had promised to set the additional rates at 100% — as he appeared to suggest last month. 'I never said a percentage, but we'll be doing quite a bit of that. We'll see what happens over the next fairly short period of time.' 3 U.S. Special Envoy Steve Witkoff will allegedly take a sterner approach in the crucial make-or-break meeting on Wednesday in an effort for the war in Ukraine to end for good. Getty Images Advertisement A source familiar with discussions insisted that sanctions are not inevitable when Trump's deadline is reached Friday, saying the administration is 'pushing hard for a deal. That's always the president's preferred outcome.' As part of his prep, Witkoff has been briefed on the historical motivations behind Putin's war on Ukraine — namely his desire to reconstitute as much of the former Soviet Union as possible, according to a US official. Last month, as Trump's rhetoric toward Moscow began to toughen, Special Presidential Envoy to Ukraine retired Gen. Keith Kellogg said that the president 'now realizes that Putin is not a business partner.' 3 President Trump said he'll see if tomorrow's sit-down will be effective before making a final decision on whether he'll slap more tariffs on Russia. REUTERS Advertisement The commander in chief — so often praised for his businesslike, transactional approach to politics — is up against a ruler who represents the opposite of that approach. That's why the earlier, more cordial approach — complete with Witkoff jovially greeting Putin at the Kremlin — did not work, according to one source. Subsequent offers of reduced sanctions and off-ramps for Russia to end its war were also not enough to persuade Moscow to change its calculus. Russia, for its part, is hoping for more of the same. Witkoff's Wednesday trip comes at the behest of the Kremlin, which invited the envoy after Trump threatened to levy the secondary sanctions. Meanwhile, as Trump's words toward Putin have grown increasingly harsh, Kremlin thought leaders have been denigrating the US president on X. Russian philosopher and Putin confidant Alexander Dugin declared Monday that Trump was crazy, an about-face from a year ago, when Dugin — nicknamed 'Putin's brain' for his purported heavy influence on the Russian leader — endorsed Trump for president in 2024. 'I come to very sad conclusion: Donald Trump is totally mad. It is the shame. We loved him,' Dugin posted to X. Last week, ex-Russian president and current deputy chair of the Kremlin's security council Dmitry Medvedev also blasted Trump for threatening sanctions.


NBC News
41 minutes ago
- NBC News
RFK Jr. cuts $500 million in mRNA vaccine contracts, dealing major blow to promising area of research
The Trump administration is terminating 22 contracts focused on developing mRNA vaccines and winding down additional federal investments in mRNA technology, Health and Human Services Secretary Robert F. Kennedy Jr. announced Tuesday. Many scientists and infectious disease experts swiftly denounced the move as a broadside on an area of research seen as particularly promising after its use in rapidly developing Covid vaccines. The projects that are being axed were funded by the Biomedical Advanced Research and Development Authority (BARDA), a Department of Health and Human Services program that works with the pharmaceutical industry to develop vaccines and other countermeasures for public health emergencies. 'This isn't just about vaccines,' Rick Bright, who directed BARDA from 2016 to 2020, said in a text message. 'It's about whether we'll be ready when the next crisis hits. Cutting mRNA development now puts every American at greater risk.' 'The Covid pandemic showed us what's possible when science moves fast,' he added. 'Dismantling that momentum now is like disbanding the fire department because the fire's out.' Kennedy said Tuesday that the terminated contracts were worth nearly $500 million. Among them is an award to the University of Texas Medical Branch and the biotechnology company Moderna to develop an mRNA-based vaccine for H5N1, the strain of bird flu that has infected dozens of people in the United States. "After reviewing the science and consulting top experts at NIH and FDA, HHS has determined that mRNA technology poses more risks and benefits for these respiratory viruses," Kennedy said in a video announcement on X. "Let me be absolutely clear, HHS supports safe, effective vaccines for every American who wants them," he added. "That's why we're moving beyond the limitations of mRNA for respiratory viruses and investing in better solutions." The move adds to mounting evidence that Kennedy, a high-profile figure in the anti-vaccine movement who softened his rhetoric after the presidential election and in confirmation hearings, is pursuing an aggressive anti-vaccine agenda that includes gutting a crucial vaccine advisory committee and cutting $2 billion from a program that supports vaccines for vulnerable children. Kennedy has referred to Covid shots as the 'deadliest vaccine ever made,' a claim contradicted by reams of studies that have found them to be safe. The Centers for Disease Control and Prevention estimates the vaccines saved more than 200,000 lives in the United States and prevented more than 1.5 million hospitalizations in the first 10 months they were available. Many pharmaceutical companies have prioritized mRNA research because the platform can easily be updated to target new viruses or variants, and scientists see it as an important tool to prepare for future pandemics. But mRNA technology has become a primary target for anti-vaccine activists who have argued — despite ongoing and sizable research — that it represents a massive safety threat. Children's Health Defense, the anti-vaccine group founded by Kennedy, applauded defunding mRNA vaccine projects under BARDA on Tuesday. "While we believe that the mRNA shots on the market are unsafe and should be off the market, this is a welcome step in the right direction. The pandemic preparedness industry as it exists today is a threat to human welfare," CEO Mary Holland said in a statement on X. In his announcement Tuesday, Kennedy suggested that mRNA vaccines fail to sufficiently protect against Covid and flu, that they can be rendered ineffective by a single mutation and that they can even prolong pandemics. But infectious disease and vaccine experts said he grossly mischaracterizes the science. "That's exactly why mRNA is so valuable: It's the only platform where you can actually update the vaccine really quickly," said Dr. Jake Scott, an infectious disease specialist at Stanford Medicine. Terminating mRNA contracts under BARDA is "a very misguided, irresponsible and I would say reckless move," Scott said. "It really does reveal a fundamental misunderstanding of how vaccines work and how a vaccine against a respiratory virus in particular should be expected to work." Kennedy said Tuesday that the BARDA funding would be shifted 'toward safer, broader vaccine platforms that remain effective even as viruses mutate," such as whole-virus vaccines, which use weakened or deactivated versions of viruses to trigger immune responses.